113 related articles for article (PubMed ID: 12033778)
1. RSV-induced immunopathology: dynamic interplay between the virus and host immune response.
Varga SM; Braciale TJ
Virology; 2002 Apr; 295(2):203-7. PubMed ID: 12033778
[No Abstract] [Full Text] [Related]
2. Polylactide-co-glycolide (PLG) microparticles modify the immune response to DNA vaccination.
Helson R; Olszewska W; Singh M; Megede JZ; Melero JA; O'Hagan D; Openshaw PJ
Vaccine; 2008 Feb; 26(6):753-61. PubMed ID: 18191308
[TBL] [Abstract][Full Text] [Related]
3. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.
Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL
J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914
[TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus and T cells: interplay between the virus and the host adaptive immune system.
Braciale TJ
Proc Am Thorac Soc; 2005; 2(2):141-6. PubMed ID: 16113482
[TBL] [Abstract][Full Text] [Related]
5. Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection.
Ayukawa H; Matsubara T; Kaneko M; Hasegawa M; Ichiyama T; Furukawa S
Clin Exp Immunol; 2004 Jul; 137(1):151-5. PubMed ID: 15196256
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity.
Ostler T; Ehl S
Eur J Immunol; 2002 Sep; 32(9):2562-9. PubMed ID: 12207340
[TBL] [Abstract][Full Text] [Related]
7. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases.
Welliver TP; Reed JL; Welliver RC
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S92-6. PubMed ID: 18820587
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus-induced CCL5/RANTES contributes to exacerbation of allergic airway inflammation.
John AE; Berlin AA; Lukacs NW
Eur J Immunol; 2003 Jun; 33(6):1677-85. PubMed ID: 12778486
[TBL] [Abstract][Full Text] [Related]
10. RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response.
Zhang W; Tripp RA
J Virol; 2008 Dec; 82(24):12221-31. PubMed ID: 18818323
[TBL] [Abstract][Full Text] [Related]
11. Peptide-based candidate vaccine against respiratory syncytial virus.
Yusibov V; Mett V; Mett V; Davidson C; Musiychuk K; Gilliam S; Farese A; Macvittie T; Mann D
Vaccine; 2005 Mar; 23(17-18):2261-5. PubMed ID: 15755607
[TBL] [Abstract][Full Text] [Related]
12. Virus clearance and immunopathology by CD8(+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma.
Ostler T; Davidson W; Ehl S
Eur J Immunol; 2002 Aug; 32(8):2117-23. PubMed ID: 12209623
[TBL] [Abstract][Full Text] [Related]
13. An immunocompromised BALB/c mouse model for respiratory syncytial virus infection.
Kong X; Hellermann GR; Patton G; Kumar M; Behera A; Randall TS; Zhang J; Lockey RF; Mohapatra SS
Virol J; 2005 Feb; 2():3. PubMed ID: 15701174
[TBL] [Abstract][Full Text] [Related]
14. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
Cyr SL; Jones T; Stoica-Popescu I; Brewer A; Chabot S; Lussier M; Burt D; Ward BJ
Vaccine; 2007 Jul; 25(29):5378-89. PubMed ID: 17561317
[TBL] [Abstract][Full Text] [Related]
15. Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice.
Dakhama A; Lee YM; Ohnishi H; Jing X; Balhorn A; Takeda K; Gelfand EW
J Allergy Clin Immunol; 2009 Jan; 123(1):138-145.e5. PubMed ID: 19056111
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of CD8+ T lymphocytes attenuates respiratory syncytial virus-enhanced allergic inflammation.
Jiang XB; Wang ZD; Zhu Y; Zhang XL; Cui XF; Yao K; Yin KS
Respiration; 2009; 77(1):76-84. PubMed ID: 18818487
[TBL] [Abstract][Full Text] [Related]
17. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
Elliott MB; Chen T; Terio NB; Chong SY; Abdullah R; Luckay A; Egan MA; Boutilier LA; Melville K; Lerch RA; Long D; Eldridge JH; Parks CL; Udem SA; Hancock GE
Vaccine; 2007 Oct; 25(41):7132-44. PubMed ID: 17850933
[TBL] [Abstract][Full Text] [Related]
18. Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies.
Voges B; Vallbracht S; Zimmer G; Bossow S; Neubert WJ; Richter K; Hobeika E; Herrler G; Ehl S
Cell Immunol; 2007 Jun; 247(2):85-94. PubMed ID: 17904538
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus-induced exaggeration of allergic airway disease is dependent upon CCR1-associated immune responses.
John AE; Gerard CJ; Schaller M; Miller AL; Berlin AA; Humbles AA; Lukacs NW
Eur J Immunol; 2005 Jan; 35(1):108-16. PubMed ID: 15593301
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the CD8+ T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice.
Lukens MV; Claassen EA; de Graaff PM; van Dijk ME; Hoogerhout P; Toebes M; Schumacher TN; van der Most RG; Kimpen JL; van Bleek GM
Virology; 2006 Aug; 352(1):157-68. PubMed ID: 16730775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
